Bio-Techne Corporation TECH
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 299.71M | 321.19M | 311.42M | 295.88M | 286.56M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 299.71M | 321.19M | 311.42M | 295.88M | 286.56M |
| Cost of Revenue | 101.68M | 109.14M | 101.98M | 102.69M | 96.36M |
| Gross Profit | 198.03M | 212.05M | 209.44M | 193.19M | 190.19M |
| SG&A Expenses | 131.42M | 98.59M | 107.54M | 111.87M | 117.57M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 259.45M | 231.67M | 232.97M | 237.68M | 238.18M |
| Operating Income | 40.27M | 89.52M | 78.45M | 58.20M | 48.38M |
| Income Before Tax | 34.69M | 70.68M | 71.23M | 50.78M | 47.99M |
| Income Tax Expenses | 6.40M | 16.06M | 20.18M | 12.78M | 9.81M |
| Earnings from Continuing Operations | 28.29M | 54.62M | 51.05M | 38.01M | 38.19M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 28.29M | 54.62M | 51.05M | 38.01M | 38.19M |
| EBIT | 40.27M | 89.52M | 78.45M | 58.20M | 48.38M |
| EBITDA | 63.99M | 113.66M | 102.62M | 82.91M | 72.72M |
| EPS Basic | 0.18 | 0.35 | 0.33 | 0.24 | 0.25 |
| Normalized Basic EPS | 0.15 | 0.37 | 0.30 | 0.22 | 0.20 |
| EPS Diluted | 0.18 | 0.35 | 0.32 | 0.24 | 0.24 |
| Normalized Diluted EPS | 0.15 | 0.37 | 0.29 | 0.22 | 0.19 |
| Average Basic Shares Outstanding | 156.80M | 156.09M | 156.33M | 155.84M | 155.46M |
| Average Diluted Shares Outstanding | 157.93M | 157.03M | 157.40M | 157.00M | 156.36M |
| Dividend Per Share | -- | 0.08 | 0.08 | 0.08 | 0.08 |
| Payout Ratio | 44.39% | 22.86% | 24.52% | 32.81% | 32.59% |